The role of FDG-PET/CT in preoperative staging of sentinel lymph node biopsy-positive melanoma patients

af Frary, Evan C., Gad, Dorte, Bastholt, Lars, Hess, Søren
Udgivet i EJNMMI Res (2016)

A Placebo-Controlled, Blinded and Randomised Study on the Effects of Recombinant Human Thyrotropin on Quality of Life in the Treatment of Thyroid Cancer

af Nygaard, Birte, Bastholt, Lars, Bennedbæk, Finn Noe, Klausen, Tobias Wirenfeldt, Bentzen, Jens
Udgivet 2013

Selection of patient reported outcomes questions reflecting symptoms for patients with metastatic melanoma receiving immunotherapy

af Tolstrup, Lærke K., Bastholt, Lars, Zwisler, Ann-Dorthe, Dieperink, Karin B., Pappot, Helle
Udgivet i J Patient Rep Outcomes (2019)

Patient-Reported Outcomes During Immunotherapy for Metastatic Melanoma: Mixed Methods Study of Patients’ and Clinicians’ Experiences

af Tolstrup, Lærke K, Pappot, Helle, Bastholt, Lars, Zwisler, Ann-Dorthe, Dieperink, Karin B
Udgivet i J Med Internet Res (2020)

Improved Progression-Free Long-Term Survival of a Nation-Wide Patient Population with Metastatic Melanoma

af Soerensen, Anne Vest, Ellebaek, Eva, Bastholt, Lars, Schmidt, Henrik, Donia, Marco, Svane, Inge Marie
Udgivet i Cancers (Basel) (2020)

Development of anti-drug antibodies is associated with shortened survival in patients with metastatic melanoma treated with ipilimumab

af Kverneland, Anders H., Enevold, Christian, Donia, Marco, Bastholt, Lars, Svane, Inge Marie, Nielsen, Claus H.
Udgivet i Oncoimmunology (2018)

Danish translation, cultural adaption and initial psychometric evaluation of the patient feedback form

af Tolstrup, Lærke K., Pappot, Helle, Zangger, Graziella, Bastholt, Lars, Zwisler, Ann-Dorthe, Dieperink, Karin B.
Udgivet i Health Qual Life Outcomes (2018)

The use of patient-reported outcomes to detect adverse events in metastatic melanoma patients receiving immunotherapy: a randomized controlled pilot trial

af Tolstrup, Lærke K., Bastholt, Lars, Dieperink, Karin B., Möller, Sören, Zwisler, Ann-Dorthe, Pappot, Helle
Udgivet i J Patient Rep Outcomes (2020)

Total Thyroidectomy for Thyroid Cancer Followed by Thyroid Storm due to Thyrotropin Receptor Antibody Stimulation of Metastatic Thyroid Tissue

af Folkestad, Lars, Brandt, Frans, Brix, Thomas, Vogsen, Marianne, Bastholt, Lars, Grupe, Peter, Krogh Petersen, Jeanette, Hegedüs, Laszlo
Udgivet i Eur Thyroid J (2017)

Large Discrepancy in the Results of Sensitive Measurements of Thyroglobulin Antibodies in the Follow-Up on Thyroid Cancer: A Diagnostic Dilemma

af Nygaard, Birte, Bentzen, Jens, Laurberg, Peter, Pedersen, Susanne Møller, Bastholt, Lars, Handberg, Aase, Rytter, Carsten, Godballe, Christian, Faber, Jens
Udgivet 2012

Depletion of T lymphocytes is correlated with response to temozolomide in melanoma patients

af Iversen, Trine Zeeberg, Brimnes, Marie Klinge, Nikolajsen, Kirsten, Andersen, Rikke Sick, Hadrup, Sine Reker, Andersen, Mads Hald, Bastholt, Lars, Svane, Inge Marie
Udgivet 2013

Phase II, Open-Label, Randomized Trial of the MEK1/2 Inhibitor Selumetinib as Monotherapy versus Temozolomide in Patients with Advanced Melanoma

af Kirkwood, John M., Bastholt, Lars, Robert, Caroline, Sosman, Jeff, Larkin, James, Hersey, Peter, Middleton, Mark, Cantarini, Mireille, Zazulina, Victoria, Kemsley, Karin, Dummer, Reinhard
Udgivet 2011

Efficacy and Safety of Vandetanib in Progressive and Symptomatic Medullary Thyroid Cancer: Post Hoc Analysis From the ZETA Trial

af Kreissl, Michael C., Bastholt, Lars, Elisei, Rossella, Haddad, Robert, Hauch, Ole, Jarząb, Barbara, Robinson, Bruce, Colzani, Raffaella, Foster, Meredith, Weiss, Richard, Schlumberger, Martin
Udgivet i J Clin Oncol (2020)

Effect of an Outreach Programme on Vandetanib Safety in Medullary Thyroid Cancer

af Bastholt, Lars, Kreissl, Michael C., Führer, Dagmar, Maia, Ana L., Locati, Laura D., Maciel, Léa, Wu, Yi, Heller, Kevin N., Webster, Alan, Elisei, Rossella
Udgivet i Eur Thyroid J (2016)

A prospective phase II trial exploring the association between tumor microenvironment biomarkers and clinical activity of ipilimumab in advanced melanoma

af Hamid, Omid, Schmidt, Henrik, Nissan, Aviram, Ridolfi, Laura, Aamdal, Steinar, Hansson, Johan, Guida, Michele, Hyams, David M, Gómez, Henry, Bastholt, Lars, Chasalow, Scott D, Berman, David
Udgivet 2011

The impact of patient characteristics and disease-specific factors on first-line treatment decisions for BRAF-mutated melanoma: results from a European expert panel study

af Ascierto, Paolo A., Bastholt, Lars, Ferrucci, Pier F., Hansson, Johan, Márquez Rodas, Iván, Payne, Miranda, Robert, Caroline, Thomas, Luc, Utikal, Jochen S., Wolter, Pascal, Kudlac, Amber, Tuson, Harriet, McKendrick, Jan
Udgivet i Melanoma Res (2018)

Real-World Impact of Immune Checkpoint Inhibitors in Metastatic Uveal Melanoma

af Bol, Kalijn Fredrike, Ellebaek, Eva, Hoejberg, Lise, Bagger, Mette Marie, Larsen, Mathilde Skaarup, Klausen, Tobias Wirenfeldt, Køhler, Ulrich Heide, Schmidt, Henrik, Bastholt, Lars, Kiilgaard, Jens Folke, Donia, Marco, Svane, Inge Marie
Udgivet i Cancers (Basel) (2019)

Sorafenib in locally advanced or metastatic, radioactive iodine-refractory, differentiated thyroid cancer: a randomized, double-blind, phase 3 trial

af Brose, Marcia S, Nutting, Christopher M, Jarzab, Barbara, Elisei, Rossella, Siena, Salvatore, Bastholt, Lars, de la Fouchardiere, Christelle, Pacini, Furio, Paschke, Ralf, KeeShong, Young, Sherman, Steven I, Smit, Johannes WA, Chung, John, Kappeler, Christian, Pena, Carol, Molnár, István, Schlumberger, Martin J
Udgivet i Lancet (2014)

Overall survival at 5 years of follow-up in a phase III trial comparing ipilimumab 10 mg/kg with 3 mg/kg in patients with advanced melanoma

af Ascierto, Paolo Antonio, Del Vecchio, Michele, Mackiewicz, Andrzej, Robert, Caroline, Chiarion-Sileni, Vanna, Arance, Ana, Lebbé, Céleste, Svane, Inge Marie, McNeil, Catriona, Rutkowski, Piotr, Loquai, Carmen, Mortier, Laurent, Hamid, Omid, Bastholt, Lars, Dreno, Brigitte, Schadendorf, Dirk, Garbe, Claus, Nyakas, Marta, Grob, Jean-Jacques, Thomas, Luc, Liszkay, Gabriella, Smylie, Michael, Hoeller, Christoph, Ferraresi, Virginia, Grange, Florent, Gutzmer, Ralf, Pikiel, Joanna, Hosein, Fareeda, Simsek, Burcin, Maio, Michele
Udgivet i J Immunother Cancer (2020)

Combined Nivolumab and Ipilimumab or Monotherapy in Previously Untreated Melanoma

af Larkin, James, Chiarion-Sileni, Vanna, Gonzalez, Rene, Grob, Jean Jacques, Cowey, C. Lance, Lao, Christopher D., Schadendorf, Dirk, Dummer, Reinhard, Smylie, Michael, Rutkowski, Piotr, Ferrucci, Pier Francesco, Hill, Andrew, Wagstaff, John, Carlino, Matteo S., Haanen, John B., Maio, Michele, Marquez-Rodas, Ivan, McArthur, Grant A., Ascierto, Paolo A., Long, Georgina V., Callahan, Margaret K., Postow, Michael A., Grossmann, Kenneth, Sznol, Mario, Dreno, Brigitte, Bastholt, Lars, Yang, Arvin, Rollin, Linda M., Horak, Christine, Hodi, F. Stephen, Wolchok, Jedd D.
Udgivet i N Engl J Med (2015)